The multicenter experience in the multidisciplinary Italian breast units: a review and update.
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
medline:
24
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
aheadofprint
Résumé
A breast unit is a multidisciplinary center specialized in the management of women with breast diseases, including breast cancer (BC). It represents a care path, passing from screening activities to diagnostic investigations, from surgery to the definition of the therapeutic strategy, from psychophysical rehabilitation to long-term checks (follow-up), and up to genetic counseling. Since 2006, following a resolution issued by the European Parliament to urge member states to activate multidisciplinary breast centers by 2016, work has been underway throughout Italy to improve the management of women with BC. In Italy, the State-Regions agreement was signed on 18 December 2014, sanctioning the establishment of breast units. These centers must adhere to specific quality criteria and requirements. In 2020, the experts of the EUSOMA group (European Society of Breast Cancer Specialists), in their latest document published, expanded the requirements of the breast units. Furthermore, Senonetwork was founded in 2012 with the aim of allowing BC to be treated in breast units that comply with European requirements to ensure equal treatment opportunities for all Italian women. Indeed, the available data indicate that the BC patient has a greater chance of better treatment in the breast units with a multidisciplinary team, thus increasing the survival rate with a better quality of life, compared to those managed in nonspecialized structures. The present review is a perspective on the current Italian reality of breast units, updated with the available literature and the most recent epidemiological data from Senonetwork and AgeNaS.
Identifiants
pubmed: 37997909
doi: 10.1097/CEJ.0000000000000853
pii: 00008469-990000000-00104
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
AIOM-AIRTUM-SIAPEC-IAP. (2022). I numeri del cancro in Italia, 2022. Intermedia Editor.
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. (2020). The requirements of a specialist breast centre. Breast 51:65–84.
Bucchi L (2011). Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes? BMC Health Serv Res 11:249.
Cardoso F, Cataliotti L, Costa A, Knox S, Marotti L, Rutgers E, et al. (2017). European Breast Cancer Conference manifesto on breast centres/units. Eur J Cancer 72:244–250.
Cataliotti L., et al. (2010). The requirements of a specialist breast unit. 2010 updated version of the revised version published in the 4th Edition of the European guidelines for quality assurance in breast cancer screening and diagnosis, supported and printed by the European Commission.
Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, et al.; EUSOMA (2007). Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer 43:660–675.
Chen CS, Liu TC, Lin HC, Lien YC (2008). Does high surgeon and hospital surgical volume raise the five-year survival rate for breast cancer? A population-based study. Breast Cancer Res Treat 110:349–356.
Chief Medical Officers’ Expert Advisory Group on Cancers (1995) A policy framework for commissioning cancer services. Department of Health and Welsh Office.
Corso G, Janssens JP, La Vecchia C (2023). Cancer prevention: innovative strategies in the role of the European Cancer Prevention Organization. Eur J Cancer Prev 32:203–206.
Costarelli L, Cianchetti E, Corsi F, Friedman D, Ghilli M, Lacaria M, et al. (2018). Microinvasive breast carcinoma: an analysis from ten Senonetwork Italia breast centres. Eur J Surg Oncol 45:147–152.
Costarelli L, Rizzo A, Bortul M, Pietribiasi F, Taffurelli M, Tinterri C, et al.; Senonetwork Italia Breast Centres Responders (2021). Pre-analytics, a national survey of Senonetwork Italia breast centers: Much still to do ahead. Eur J Surg Oncol 47:240–244.
Deandrea S, Ferrè F, D’Antona R, Angiolini C, Bortul M, Bucchi L, et al. (2022). Integrating mammography screening programmes into specialist breast centres in Italy: insights from a national survey of Senonetwork breast centres. BMC Health Serv Res 22:723.
European Parliament resolution on breast cancer in the enlarged European Union. (2006). http://bit.ly/1XT0WTu. [Accessed June 2023].
European Parliament resolution on breast cancer in the European Union. (2003). http://bit.ly/1QEU860. [Accessed June 2023].
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403.
Fortunato L, d’Amati G, Taffurelli M, Tinterri C, Marotti L, Cataliotti L (2021). Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey. Clin Breast Cancer 21:e165–e167.
Franceschini G, Di Leone A, Masetti R (2014). The Breast Unit Update on advantages and the open issues. Ann Ital Chir 85:407–412.
Gazzani D, Dai Prè A, Sandrini R, Governa M, Favaro A, Zogno A, et al. (2021). The process of EUSOMA certification improves the quality of breast cancer care: the experience of an Italian EUSOMA certificated Breast Unit (BU) according to the results of a cross-sectional study. Recenti Prog Med 112:458–464.
Gillis CR, Hole DJ (1996). Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 312:145–148.
Greco M, Marotti L; Eusoma Executive Committee (2006). Background to Eusoma guidelines and statements. Eur J Cancer 42:2200–2204.
Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, et al. (2022). Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer 127:558–568.
Hébert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005). Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104:1343–1348.
http://www.senonetwork.it. [Accessed June 2023].
https://pne.agenas.it. [Accessed June 2023].
Johansson ALV, Larønningen S, Skovlund CW, Kristiansen MF, Mørch LS, Friis S, et al. (2022). The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: a comparison across the Nordic countries during 2020. Int J Cancer 151:381–395.
Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS (2012). Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 344:e2718.
Klinger M, Losurdo A, Lisa AVE, Morenghi E, Vinci V, Corsi F, et al. (2022). Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 Senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Breast Cancer Res Treat 191:355–363.
Losurdo A, Lisa AVE, Tomatis M, Ponti A, Montemezzi S, Bonzano E, et al.; Senonetwork Working Group (2022). Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience. Breast Cancer Res Treat 196:87–95.
Magnoni F, Corso G (2022). Progress in breast cancer surgical management. Eur J Cancer Prev 31:551–553.
Mosconi P, Kodraliu G (1999). Italian forum of Europa Donna: a survey of breast cancer associations. Health Expect 2:44–50.
Richards M, Sainsbury R, Kerr D (1997). Inequalities in breast cancer care and outcome. Br J Cancer 76:634–638.
Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, et al. (2012). Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol 23:853–859.
Saz Parkinson Z, Bramesfeld A, Deandrea S, López-Alcalde J, Neamţiu L, Pylkkänen L, et al. (2017). Report of a European survey on the implementation of breast units. Luxembourg: Publications Office of the European Union.
Senato della Repubblica Italiana XVI Legislatura: Documento approvato dalla XII Commissione (Igiene e Sanità) 8 Marzo 2011. Conclusione dell’indagine conoscitiva sulle malattie ad andamento degenerativo di particolare rilevanza sociale con specifico riguardo al tumore della mammella, alle malattie reumatiche croniche ed alla sindrome HIV. 18-35. Bianconi L: Legislatura 16a - 12a Commissione permanente – Resoconto sommario n.351 del 24/07/2012. http://www.senato.it/japp/bgt/showdoc/frame.jsp?tipodoc=SommComm&leg=16&id=00671063&part=doc_dc-sedetit_sldc&parse=no.
Serra M, Li AQ, Cataliotti L, Cianchetti E, Corsi F, De Vita R, et al.; authors are grateful to (2020). Aesthetic results following breast cancer surgery: A prospective study on 6515 cases from ten Italian Senonetwork breast centers. Eur J Surg Oncol 46:1861–1866.
Stefoski Mikeljevic J, Haward RA, Johnston C, Sainsbury R, Forman D (2003). Surgeon workload and survival from breast cancer. Br J Cancer 89:487–491.
EUSOMA. (2000). The requirements of a specialist breast unit. Eur J Cancer 39:847.
Trama A, Bernasconi A, Botta L, Di Cosimo S, Miceli R, Claps M, et al. (2022). COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020. Int J Cancer 151:1502–1511.
Vrijens F, Stordeur S, Beirens K, Devriese S, Van Eycken E, Vlayen J (2012). Effect of hospital volume on processes of care and 5-year survival after breast cancer: a population-based study on 25000 women. Breast 21:261–266.
Wilson AR, Marotti L, Bianchi S, Biganzoli L, Claassen S, Decker T, et al.; EUSOMA (European Society of Breast Cancer Specialists) (2013). The requirements of a specialist Breast Centre. Eur J Cancer 49:3579–3587.